Webcast Design for Success: Developability & Technology Selection

Design for Success: Developability & Technology Selection

 · America/New_York

About This Webcast

An optimal formulation is the simplest option that meets the product and patient’s needs. A technology agnostic approach based on a fundamental understanding of API properties, a well-defined yet flexible target product profile, and a mindset for scalability and commercial relevance leads to success in formulation development and drug product design. In the modern landscape for oral dosage forms, enabled formulations for bioavailability enhancement are increasingly common. Drug candidates are no longer ruled out in discovery due to low solubility or low permeability, allowing for more explicit optimization of molecular properties that drive safety and efficacy while relying on formulation and delivery technologies to overcome the barriers associated with limited oral absorption. A developability assessment to determine the most appropriate technology should take into consideration molecular properties of the API, bio-performance modeling to predict absorption as a function of form and formulation, and a comprehensive understanding of the patient population, product design, and program strategy. In this webinar, we’ll discuss how to use this approach to strategically guide formulation technology selection. When an enabled formulation is required, we’ll discuss how these same tools can further help to guide formulation development and product design.

Speakers

Erica Schlesinger, PhD

Erica Schlesinger, PhD

Vice President of Technical Development, Process & Product Development , Serán Bioscience

Erica Schlesinger is Serán’s Vice President of Technical Development. She leads a team that applies scientific rationale and engineering design to problem-solving and pharmaceutical product development. Her research interests include spray-dried biologics (mAb, Phage, Virus, Whole Cells) and controlled-release technologies for long-acting therapeutics. Erica has over 15 years of experience in pharmaceutical formulation development, process chemistry, and the early-stage development of novel drug delivery systems, and prior to joining Serán, she worked at Genentech, Seattle Genetics, and Regeneron. Erica holds an undergraduate degree in Chemical Engineering from Cornell University and a Ph.D. in Bioengineering from the Joint Graduate Group in Bioengineering at the University of California San Francisco and UC Berkeley.

Tim Wright

Tim Wright

Editor-in-Chief , Contract Pharma

Tim Wright is the editor of Contract Pharma magazine, which is a trade publication serving thousands of pharma and biopharma outsourcing professionals. He has been editor at Rodman Media since 2006. Prior to his position at Contract Pharma, he was an editor at Coatings World and Nonwovens Industry publications. Tim has a B.A. from Montclair State University in New Jersey where he studied English literature and journalism.